Maternal Plasma and Cord Blood Concentration Profiles of Duloxetine During the Peripartum Period and Their Associations With the Modified Finnegan Score

Ther Drug Monit. 2022 Apr 1;44(2):351-352. doi: 10.1097/FTD.0000000000000943.

Authors

Reina Taguchi¹, Takafumi Naito^{1

2}, Koji Suzuki¹, Yuko Kurosawa¹, Hiroaki Itoh³, Junichi Kawakami¹

Affiliations

¹ Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
² Department of Pharmacy, Shinshu University Hospital, Matsumoto, Nagano, Japan, and.
³ Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.

PMID: 34812767
DOI: 10.1097/FTD.0000000000000943

No abstract available

Publication types

Letter

MeSH terms

Duloxetine Hydrochloride
Fetal Blood*
Humans
Peripartum Period*
Plasma
Risk Factors

Substances

Duloxetine Hydrochloride